Oncology
0 drugs are in development for Prostate Cancer (Adenocarcinoma).
- Companies
- 0
- Clinical trials
- 9
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Prostate Cancer (Adenocarcinoma) pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
About this indication
Prostate Cancer (Adenocarcinoma) context
Oncology·MeSH: Prostatic Neoplasms (D011471)
Narrower concept of MeSH descriptor Prostatic Neoplasms
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
Frequently asked questions
How many clinical trials target Prostate Cancer (Adenocarcinoma)?
There are 9 clinical trials targeting Prostate Cancer (Adenocarcinoma) tracked by BioSniper.
What is the prevalence of Prostate Cancer (Adenocarcinoma)?
The estimated prevalence of Prostate Cancer (Adenocarcinoma) is approximately 256.0 per 100,000 population.